While having cytotoxic effects when acutely administered to tumors, the chronic presence of TNFα in breast tumor sites leads to increased tumor aggressiveness; IL-1β up-regulates processes that contribute to higher angiogenesis, tumor growth and progression in breast cancer (e.g., [21-26]). This evidence concerns the gene IL1B and breast cancer.